"label","id","uuid:ID","name","description","instanceType","text"
"","Objective_1","7d4528fb-489c-4ee9-97e8-e7beb4628da2","OBJ1","Main objective","Objective","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"","Objective_2","452cfc6a-c059-454f-86d4-c04bbc7f6df1","OBJ2","Safety","Objective","To document the safety profile of the xanomeline TTS."
"","Objective_3","0999e0b9-8adb-4e27-af09-027a1baf95f2","OBJ3","Behaviour","Objective","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
